Clinical Trials on Glycogenesis Type II in Belgium

Total 1915 results

Universitair Ziekenhuis Brussel

Completed

Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients

Malignant Melanoma

Belgium
Amgen

Completed

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders (TAUSSIG)

Severe Familial Hypercholesterolemia

Italy, Czechia, United States, Israel, New Zealand, South Africa, France, Spain, Australia, Belgium, Canada, Netherlands, Hong Kong, Brazil, United Kingdom, Greece, Japan, Lebanon
Ludwig Institute for Cancer Research

Terminated

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Metastatic Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Centre Georges Francois Leclerc

Completed

Simultaneous Integrated Boost (SIB)- IMRT

Carcinoma, Squamous Cell

Belgium
Universitaire Ziekenhuizen KU Leuven
DexCom, Inc.

Completed

Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes (ALERTT1)

Type 1 Diabetes Mellitus

Belgium
AZ-VUB

Unknown

Beta Cell Function in (Pre) Type 1 Diabetes

Type 1 Diabetes

Belgium
University Hospital, Ghent

Terminated

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) (TRACE)

Hepatocellular Carcinoma

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Completed

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Type1 Diabetes

Belgium, Netherlands
University Hospital, Ghent

Enrolling by invitation

Validation of the Global Polypectomy Assessment Tool (GPAT) (GPAT)

Colo-rectal Cancer | Colorectal Adenoma | Colorectal Polyp

Belgium
University Ghent
Belgian Federation Against Cancer

Completed

Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis (MMT)

Peritoneal Carcinomatosis

Belgium
CDx Diagnostics

Completed

Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma

Barrett Esophagus | Esophageal Adenocarcinoma | Esophageal Dysplasia

Belgium
Hasselt University
Jessa Hospital

Completed

Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.

Diabetes Mellitus, Type 1

Belgium
Erasme University Hospital
AZ Sint-Jan AV; Cliniques universitaires Saint-Luc- Université Catholique de... and other collaborators

Completed

PAtient-PHYsician Relationship Assessment (PAPHYRA)

Hepatocellular Carcinoma

Belgium
BTG International Inc.

Terminated

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Belgium
Hasselt University
Jessa Hospital

Completed

Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity (GIIADMT1)

Diabetes Mellitus, Type 1

Belgium
Universitair Ziekenhuis Brussel
University Hospital, Ghent

Recruiting

Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)

Melanoma

Belgium
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment (COBOX)

Colorectal Peritoneal Carcinomatosis

Belgium
Sanofi

Recruiting

A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

Glycogen Storage Disease Type II

Belgium, United States, Italy, Spain, Taiwan, United Kingdom, Netherlands, France, Germany
Universitair Ziekenhuis Brussel

Active, not recruiting

Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma (GlitIpNi)

Glioblastoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology (MUSA1)

Myoma;Uterus | Sarcoma Uterus

Belgium
Bart Neyns
Pfizer

Completed

A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma (AxiGII)

Glioblastoma Multiforme

Belgium
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Bart Neyns

Completed

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Melanoma

Belgium
Novo Nordisk A/S

Completed

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes (REPAMET)

Diabetes Mellitus, Type 2 | Diabetes

Luxembourg, Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Head and Neck Cancer

Belgium
Asylia Diagnostics BV

Recruiting

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Melanoma | Lung Cancer

Belgium
Novo Nordisk A/S

Completed

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin (Mix2Mix)

Diabetes Mellitus, Type 2 | Diabetes

Belgium, Luxembourg
American University of Beirut Medical Center
Bristol-Myers Squibb

Terminated

A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma

Cholangiocarcinoma

Lebanon, Belgium, Luxembourg
Universitaire Ziekenhuizen KU Leuven

Unknown

Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults (FUBEO)

Osteosarcoma | Ewing Sarcoma

Belgium
Jessa Hospital
Wit-Gele Kruis Limburg; KLAV; Ferm Thuiszorg; I-mens; Vlaams Patiëntenplatform; Wit-Gele... and other collaborators

Recruiting

Visualisation of a Digital Care Pathway.

Type 2 Diabetes | Patient Empowerment | Patient Acceptance of Health Care | Multidisciplinary Communication | Empowerment

Belgium
University Hospital, Ghent
University Ghent

Completed

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

Belgium
Université Catholique de Louvain
European Society for Clinical Nutrition and Metabolism

Completed

Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia (MicroAML)

Acute Myeloid Leukemia | Cachexia

Belgium
University Hospital, Ghent

Completed

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Colorectal Neoplasms

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Leiomyomas

Belgium
University Hospital, Ghent

Recruiting

RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly (BASINEL)

Elderly | Basal Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery (HNSCC)

Surgery | Head and Neck Squamous Cell Carcinoma | Growth Factor

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Genomic Analysis of Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Belgium
Universitair Ziekenhuis Brussel
Kom Op Tegen Kanker

Recruiting

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Breast Cancer | Melanoma (Skin) | Malignant Solid Tumor

Belgium
Sanofi

Recruiting

Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa (Baby-COMET)

Glycogen Storage Disease Type II

Belgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
Universitair Ziekenhuis Brussel
RIZIV

Completed

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma (DC-MEL)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

Belgium
Grand Hôpital de Charleroi

Recruiting

Prospective Observational Study of Diffuse Large-cell B Lymphoma (LBDGCréfract)

Lymphoma, B-Cell

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

Neurofibromatosis Type 1

Belgium
Moens Maarten

Recruiting

Differential Target Multiplexed Spinal Cord Stimulation (DETECT)

Failed Back Surgery Syndrome | Persistent Spinal Pain Syndrome Type 2

Belgium
University Hospital, Ghent

Completed

The Hysteroscopic Morcellator (HM). (HM)

Large Intrauterine Polyps | Smaller Type 0 and 1 Myomas | Residual Placental Tissue

Belgium, Netherlands
Cliniques universitaires Saint-Luc- Université...
Cliniques Universitaires UCL de Mont-Godinne, Dr Joseph Kerger; Cliniques Saint-Pierre...

Unknown

Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC) (PASCE)

Carcinoma, Squamous Cell

Belgium
University Hospital, Antwerp

Completed

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission (CCRG 05-001)

Acute Myeloid Leukemia (AML)

Belgium
Jules Bordet Institute

Recruiting

Multidisciplinary Approach to Fatigue

Breast Cancer | Germ Cell Tumor

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer (UCL-Xenog)

Squamous Cell Carcinoma of the Head and Neck

Belgium

Clinical Trials on Glycogenesis Type II in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations